1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. Larimar Therapeutics Acquires Zafgen

M&A Deal Summary

Larimar Therapeutics Acquires Zafgen

On May 29, 2020, Larimar Therapeutics acquired life science company Zafgen

Acquisition Highlights
  • This is Larimar Therapeutics’ 1st transaction in the Life Science sector.
  • This is Larimar Therapeutics’ 1st transaction in the United States.
  • This is Larimar Therapeutics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2020-05-29
Target Zafgen
Sector Life Science
Buyer(s) Larimar Therapeutics
Deal Type Merger

Target

Zafgen

Boston, Massachusetts, United States
Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders. Zafgen was founded in 2005 and is based in Boston, Massachusetts.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Larimar Therapeutics

Bala Cynwyd, Pennsylvania, United States
Category Company
Sector Life Science
Employees65
Revenue 42M USD (2023)
DESCRIPTION

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar Therapeutics is based in Bala Cynwyd, Pennsylvania.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal